Joseph R. Arron

Acentech (United States) — United States

Medicine · Health Sciences

60h-index18.8kcitations184works3.52yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Asthma and respiratory diseases(101), IL-33, ST2, and ILC Pathways(46), Respiratory and Cough-Related Research(30), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis(25), Eosinophilic Esophagitis(17)

Publications182 total

Single-Cell Reconstruction of Human Basal Cell Diversity in Normal and Idiopathic Pulmonary Fibrosis Lungs.
UNC Libraries·2025Open Access
Structural Basis for Integrin-Independent Activity of Latent TGF-β3 9072
The Journal of Immunology·2025Open Access
S105 The airway transcriptome in type2 cytokine biomarker-high and -low severe asthma
2025
The airway transcriptome in type2 cytokine biomarker-high, -intermediate and -low severe asthma
2025
Breaking the cycle: should we target inflammation, fibrosis, or both?
Frontiers in Immunology·2025· 3 citedOpen Access
Mechanisms of TRAF Signaling
Digital Commons - RU (Rockefeller University)·2025Open Access
Transcriptional fingerprinting of regulatory T cells: ensuring quality in cell therapy applications
Frontiers in Immunology·2025Open Access
POS0034 REGULATE-RA: A Phase 1 Study of CAR-T Regulatory Cells Targeting Citrullinated Proteins in Refractory Rheumatoid Arthritis: Interim Safety and Tolerability
Annals of the Rheumatic Diseases·2025· 1 citedOpen Access
YAP/TAZ activity in PDGFRα-expressing alveolar fibroblasts modulates AT2 proliferation through Wnt4
Cell Reports·2025· 4 citedOpen Access
Dual inhibition of TGFβ2,3 is severely toxic, whereas selective inhibition of TGFβ1, 2, or 3 and dual inhibition of TGFβ1,2 is generally tolerated in mouse and cynomolgus monkey toxicology studies
Toxicological Sciences·2025· 2 cited
Urinary thromboxane and isoprostane levels are elevated in symptom-high T2-biomarker-low severe asthma
ERJ Open Research·2025Open Access
The effects of inhaled corticosteroids on healthy airways
2024
The effects of inhaled corticosteroids on healthy airways
Allergy·2024· 12 citedOpen Access
Opportunities and challenges for innovative and equitable healthcare
Nature Reviews Drug Discovery·2024· 8 cited
Isoform-selective TGF-β3 inhibition for systemic sclerosis
Med·2024· 22 citedOpen Access
The effects of inhaled corticosteroids on healthy airways
2023· 2 citedOpen Access
An interleukin 6 responsive plasma cell signature is associated with disease progression in systemic sclerosis interstitial lung disease
iScience·2023· 17 citedOpen Access
Relative abundance of Haemophilus as a component of the respiratory microbiome is not associated with airway epithelial MUC5AC staining
2023
Urinary eicosanoids - novel biomarkers in T2-low severe asthma
2023· 1 cited
Utilizing PK and PD Biomarkers to Guide the First-in-Human Starting Dose Selection of MTBT1466A: A Novel Humanized Monoclonal Anti-TGFβ3 Antibody for the Treatment of Fibrotic Diseases
Journal of Pharmaceutical Sciences·2023· 4 citedOpen Access
page 1 of 10Next →

Frequent Co-authors

David F. Choy(18), Yongwon Choi(10), Guiquan Jia(8), Zora Modrušan(8), Peter Bradding(8), Thirumalai R. Ramalingam(8), Paul J. Wolters(8), Prescott G. Woodruff(7), Alexander R. Abbas(7), John V. Fahy(6), Lawren C. Wu(6), John G. Matthews(6), Liam G. Heaney(6), Jeffrey M. Harris(5), Cécile Holweg(5), Sofia Mosesova(4), Brian Wong(4), Daryle J. DePianto(4), Hans D. Brightbill(4), Peter Howarth(4)